BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 18695891)

  • 41. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
    Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E
    Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB.
    Wei LH; Lai KP; Chen CA; Cheng CH; Huang YJ; Chou CH; Kuo ML; Hsieh CY
    Oncogene; 2005 Jan; 24(3):390-8. PubMed ID: 15531921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells.
    Mizuma M; Katayose Y; Yamamoto K; Shiraso S; Sasaki T; Yabuuchi S; Oda A; Masuda K; Rikiyama T; Onogawa T; Ohtsuka H; Motoi F; Egawa S; Unno M
    Anticancer Res; 2008; 28(5A):2669-77. PubMed ID: 19035293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential effect of imatinib and synergism of combination treatment with chemotherapeutic agents in malignant glioma cells.
    Ren H; Tan X; Dong Y; Giese A; Chou TC; Rainov N; Yang B
    Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):241-52. PubMed ID: 19159435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
    Golubovskaya VM; Virnig C; Cance WG
    Mol Carcinog; 2008 Mar; 47(3):222-34. PubMed ID: 17849451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Photodynamic targeting of EGFR does not predict the treatment outcome in combination with the EGFR tyrosine kinase inhibitor Tyrphostin AG1478.
    Weyergang A; Kaalhus O; Berg K
    Photochem Photobiol Sci; 2008 Sep; 7(9):1032-40. PubMed ID: 18754049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of apoptosis and inhibition of telomerase activity in human lung carcinoma cells by the water extract of Cordyceps militaris.
    Park SE; Yoo HS; Jin CY; Hong SH; Lee YW; Kim BW; Lee SH; Kim WJ; Cho CK; Choi YH
    Food Chem Toxicol; 2009 Jul; 47(7):1667-75. PubMed ID: 19393284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth.
    Shushan A; Rojansky N; Laufer N; Klein BY; Shlomai Z; Levitzki R; Hartzstark Z; Ben-Bassat H
    Hum Reprod; 2004 Sep; 19(9):1957-67. PubMed ID: 15205403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human corneal epithelial cell proliferation by epiregulin and its cross-induction by other EGF family members.
    Morita S; Shirakata Y; Shiraishi A; Kadota Y; Hashimoto K; Higashiyama S; Ohashi Y
    Mol Vis; 2007 Nov; 13():2119-28. PubMed ID: 18079685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
    Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
    Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination of the EGFR tyrosine kinase inhibitor AG1478 and 5-FU: no synergistic effect on EGFR phosphorylation, cell proliferation and apoptosis induction.
    Yagublu V; Ahmadova Z; Hajiyeva Y; Hafner M; Keese M
    Anticancer Res; 2013 Sep; 33(9):3753-8. PubMed ID: 24023306
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
    Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
    J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Receptor tyrosine kinase inhibition suppresses growth of pediatric renal tumor cells in vitro.
    Naraghi S; Khoshyomn S; DeMattia JA; Vane DW
    J Pediatr Surg; 2000 Jun; 35(6):884-90. PubMed ID: 10873031
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer.
    Sun PM; Wei LH; Luo MY; Liu G; Wang JL; Mustea A; Könsgen D; Lichtenegger W; Sehouli J
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):249-57. PubMed ID: 16519988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of c-erbB-2 expression an activity in human ovarian carcinoma cells by hypericin.
    Hwang MS; Yum YN; Joo JH; Kim S; Lee KK; Gee SW; Kang HI; Kim OH
    Anticancer Res; 2001; 21(4A):2649-55. PubMed ID: 11724334
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
    Gao XD; Chen YR
    Chin Med J (Engl); 2007 May; 120(9):755-60. PubMed ID: 17531113
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase.
    Ellis AG; Doherty MM; Walker F; Weinstock J; Nerrie M; Vitali A; Murphy R; Johns TG; Scott AM; Levitzki A; McLachlan G; Webster LK; Burgess AW; Nice EC
    Biochem Pharmacol; 2006 May; 71(10):1422-34. PubMed ID: 16522318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.
    Huang X; Gao L; Wang S; Lee CK; Ordentlich P; Liu B
    Cancer Res; 2009 Nov; 69(21):8403-11. PubMed ID: 19826038
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HTERT mRNA expression correlates with matrix metalloproteinase-1 and vascular endothelial growth factor expression in human breast cancer: a correlative study using RT-PCR.
    Mansfield L; Subramanian A; Devalia H; Jiang W; Newbold RF; Mokbel K
    Anticancer Res; 2007; 27(4B):2265-8. PubMed ID: 17695512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells.
    Bocca C; Bozzo F; Martinasso G; Canuto RA; Miglietta A
    Br J Nutr; 2008 Oct; 100(4):739-50. PubMed ID: 18304389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.